Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.75 USD | -1.04% | -3.37% | -10.60% |
May. 03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
May. 02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.